{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:42:37Z","timestamp":1783107757881,"version":"3.54.6"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Common symptoms of Chronic Non-atrophic Gastritis (CNAG) include nausea, stomach distension, and abdominal pain. The Houtou Jianweiling Tablet (HTJWT) is a chinese patent medicine (CN1368229A) and it has been used clinically for more than 20\u00a0years with proven clinical efficacy in treating CNAG, prompted us to establish the clinical efficacy and safety of HTJWT on patients with mild to moderate CNAG symptoms in Pakistani population.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This phase II, double-blind, randomized, parallel-controlled trial was conducted in a single center between November 2022 and February 2023 in Pakistan. In a ratio of 1:1, total 240 CNAG patients with erosion identified by pathological biopsy and gastroscopy were randomly assigned to control (Omeprazole) group (<jats:italic>n<\/jats:italic> = 120) and the treatment (HTJWT) group (<jats:italic>n<\/jats:italic> = 120). Patients in the treatment group received orally four HTJWT (0.38g\/tablet), three times a day and one placebo of Omeprazole enteric-coated tablet prior to breakfast, daily. On the other hand, patients in the control group received one Omeprazole enteric-coated tablet (20 mg\/tablet) prior to breakfast and four placebo of HTJWT, thrice a day. The patients consumed the investigated drugs (i.e., treatment and control) treatment regimen was followed for a duration of 28\u00a0days. The safety of the patients were evaluated through adverse events, serious adverse events and laboratory tests such as blood biochemistry, urine analysis, liver and renal function tests. Vital signs like; blood pressure, pulse rate, body temperature, respiratory rate for all the patients were recorded. The cardiac status of the patients were assessed through electrocardiogram (ECG). The primary efficacy indicators were the improvement rate of gastric distention and gastralgia as the main clinical symptoms. Secondary indicators were visual analogue score (VAS); improvement rate of secondary clinical symptoms and signs; improvement rate of total clinical signs and symptoms; the disappearance\/remission rate of Gastric pain and, remission\/disappearance time of gastric distension; and the negative conversion rate of <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>). The outcomes among each group were compared using the chi-square test.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Patients in both groups had good drug compliance (80%\u2013120%), and there was no statistically significant difference in the patients\u2019 baseline characteristics. The clinical improvement rate was found to be 91.1% in the treatment group and 91.0% in the control group with negligible variation among the two groups (<jats:italic>p<\/jats:italic> = 0.9824; 95% confidence interval: -0.0781\u20130.0798). Similarly, hardly no difference was found in the negative conversion rate of <jats:italic>H. pylori<\/jats:italic> between the treatment group and the control group (i.e., 70.1% and 71.8% respectively, <jats:italic>p<\/jats:italic> = 0.8125). There were no significant differences in respiratory rate, vital signs, blood pressure, laboratory results for blood biochemistry, urine analysis, liver and renal function tests between the two groups. The ECG assessment carried out for the treatment and control group revealed no considerable difference. Margin variation in the disappearance time of gastric pain (<jats:italic>p<\/jats:italic> = 0.1860) and remission rate (<jats:italic>p<\/jats:italic> = 0.5784) between the two groups were observed. The control group exhibited a faster remission period for gastrointestinal discomfort indications as compared to treatment group (<jats:italic>p<\/jats:italic> = 0.0430). Only one patient in the control group experienced mild to moderate adverse events, namely,; epigastric pain and dyspepsia. The results were consistent with the intention-to-treat and per-protocol analysis that included patients who were 100% compliant to the assigned therapy.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The lower limit of confidence interval (CI, 95%) for the differences in the effective rate between the treatment and the control groups was found to be \u22120.0781 which is greater than \u22120.15, hence the treatment group is non-inferior to the control group. The therapeutic dosage used in the trial and treatment period did not cause any significant adverse event, and there were no obvious changes in the ECG profile, vital signs and biochemistry of the patients. Based on the clinical efficacy evaluation and reported adverse events, it can be concluded that the HTJWT is a safe and effective traditional chinese medicine for the treatment of patients suffering from chronic non-atrophic gastritis with mild to moderate symptoms.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration<\/jats:bold>: [<jats:ext-link>www.clinicaltrials.gov<\/jats:ext-link>], identifier [NCT04672018].<\/jats:p>","DOI":"10.3389\/fphar.2024.1293272","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T15:10:31Z","timestamp":1708355431000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial"],"prefix":"10.3389","volume":"15","author":[{"given":"Muhammad Raza","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samreen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehrosh Naz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shafiullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeezullah","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Chengdong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Daijun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1365-2036.2002.01336.x","article-title":"The long\u2010term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis","volume":"16","author":"Annibale","year":"2002","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"115341","DOI":"10.1016\/j.jep.2022.115341","article-title":"Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: a multicentre, double-blind, randomized controlled clinical trial","volume":"294","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1517\/14656566.2012.747510","article-title":"Current pharmacotherapy options for gastritis","volume":"13","author":"den Hollander","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"B5","first-page":"06","article-title":"Effect analysis of memory alloy patellar claw in the treatment of patella fractures","author":"Dong-yun","year":"2012","journal-title":"Heilongjiang Med. Pharm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40545-019-0200-3","article-title":"Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults","volume":"13","author":"El-Dahiyat","year":"2020","journal-title":"J. Pharm. policy Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2327-5162.1000231","article-title":"Brief review on the causes, diagnosis and therapeutic treatment of gastritis disease","volume":"6","author":"Elseweidy","year":"2017","journal-title":"Altern. Integr. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1751-2980.12593","article-title":"Chinese consensus on chronic gastritis (2017, Shanghai)","volume":"19","author":"Fang","year":"2018","journal-title":"J. Dig. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1443-9573.2007.00295.x","article-title":"Consensus on chronic gastritis in China--Second national consensus meeting on chronic gastritis (14-16 september 2006 Shanghai, China)","volume":"8","author":"Fang","year":"2023","journal-title":"J. Dig. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.21010\/ajtcam.v14i4.33","article-title":"Chinese herbal decoction as a complementary therapy for atrophic gastritis: a systematic review and meta-analysis","volume":"14","author":"Fang","year":"2017","journal-title":"Afr. J. Traditional, Complementary Altern. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0246619","DOI":"10.1371\/journal.pone.0246619","article-title":"Prevalence and associated risk factors of gastritis among patients visiting saint Paul hospital millennium medical college, addis ababa, Ethiopia","volume":"16","author":"Feyisa","year":"2021","journal-title":"Plos one"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16847","DOI":"10.1002\/jcp.28363","article-title":"Herbal medicine as an auspicious therapeutic approach for the eradication of Helicobacter pylori infection: a concise review","volume":"234","author":"Ghasemian","year":"2019","journal-title":"J. Cell. Physiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2011.00010","article-title":"Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine","volume":"2","author":"He","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/srep01543","article-title":"Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients","volume":"3","author":"Li","year":"2013","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/sjg.SJG_573_16","article-title":"Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis","volume":"23","author":"Li","year":"2017","journal-title":"Saudi J. gastroenterology official J. Saudi Gastroenterology Assoc."},{"key":"B18","first-page":"666","article-title":"Comparison of analgesic effect between locally vinegar-processed preparation of fresh rhizoma Corydalis and traditionally vinegar-processed rhizoma Corydalis","volume":"15","author":"Liu","year":"1990","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B19","first-page":"309","article-title":"Effect of Houtou Jianweiling Pian on gastric sensitivity and expression of 5-HT of rats with functional dyspepsia","volume":"29","author":"Lu-qing","year":"2021"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5772\/23221","article-title":"New approaches in gastritis treatment","volume-title":"Gastritis and gastric cancer-new insights in gastroprotection, diagnosis and treatments","author":"Marcial","year":"2011"},{"key":"B22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.15171\/ps.2018.33","article-title":"New natural marine antacid drug from cuttlebone","volume":"24","author":"Mostoufi","year":"2018","journal-title":"Pharm. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1142\/S0192415X95000201","article-title":"Effect of liu-junzi-tang on the symptom of bitter taste in patients with chronic gastritis","volume":"23","author":"Motoo","year":"1995","journal-title":"Am. J. Chin. Med."},{"key":"B24","first-page":"600","article-title":"Research of alcohol extract of Paeonia lactiflora pall in anti-inflammatory and analgesic effect","volume":"21","author":"Ou-Yang","year":"2008","journal-title":"Shu Li Yi Yao Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jep.2013.01.029","article-title":"Chaihu-Shugan-San, an oriental herbal preparation, for the treatment of chronic gastritis: a meta-analysis of randomized controlled trials","volume":"146","author":"Qin","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"B26","first-page":"532","article-title":"The healing effect of licorice (Glycyrrhiza glabra) on Helicobacter pylori infected peptic ulcers","volume":"18","author":"Rahnama","year":"2013","journal-title":"J. Res. Med. Sci. Official J. Isfahan Univ. Med. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1046\/j.1365-2036.2002.01301.x","article-title":"Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading","volume":"16","author":"Rugge","year":"2002","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.humpath.2004.12.008","article-title":"Staging and grading of chronic gastritis","volume":"36","author":"Rugge","year":"2005","journal-title":"Hum. Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S373","DOI":"10.1016\/S1590-8658(11)60593-8","article-title":"Gastritis: the histology report","volume":"43","author":"Rugge","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11938-020-00298-8","article-title":"Gastritis: an update in 2020","volume":"18","author":"Rugge","year":"2020","journal-title":"Curr. Treat. Options Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/BF01745887","article-title":"Chronic gastritis","volume":"44","author":"Schindler","year":"1966","journal-title":"Klin. Wochenschr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","article-title":"Chronic gastritis","volume":"50","author":"Sipponen","year":"2015","journal-title":"Scand. J. gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1440-1746.2010.06536.x","article-title":"The Sydney System for classification of gastritis 20 years ago","volume":"26","author":"Sipponen","year":"2011","journal-title":"J. Gastroenterology Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1472-6882-13-227","article-title":"Metabolic markers and microecological characteristics of tongue coating in patients with chronic gastritis","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Complementary Altern. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"117353","DOI":"10.1016\/j.jep.2023.117353","article-title":"The ethnopharmacology, phytochemistry and pharmacology of the genus Hericium","author":"Tan","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11655-012-0960-y","article-title":"Clinical practice guideline of Chinese medicine for chronic gastritis","volume":"18","author":"Tang","year":"2012","journal-title":"Chin. J. Integr. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/jbcpp-2014-0093","article-title":"Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress","volume":"26","author":"Thomas","year":"2015","journal-title":"J. basic Clin. physiology Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2471\/blt.07.042820","article-title":"Herbal medicine research and global health: an ethical analysis","volume":"86","author":"Tilburt","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0181546","DOI":"10.1371\/journal.pone.0181546","article-title":"A unique polysaccharide purified from Hericium erinaceus mycelium prevents oxidative stress induced by H2O2 in human gastric mucosa epithelium cell","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.88504","article-title":"Gastritis treated by Chinese medicine","volume-title":"Gastritis-new approaches and treatments","author":"Wang","year":"2019"},{"key":"B41","volume-title":"Modern surgical pathology e-book","author":"Weidner","year":"2009"},{"key":"B42","first-page":"294","article-title":"Upper gastrointestinal bleeding in adults: evaluation and management","volume":"101","author":"Wilkins","year":"2020","journal-title":"Am. Fam. physician"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e15710","DOI":"10.1097\/MD.0000000000015710","article-title":"Efficacy of traditional Chinese medicine for chronic gastritis: a meta-analysis of randomized controlled trials","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1745-6215-15-272","article-title":"The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"Trials"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1293272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T15:10:38Z","timestamp":1708355438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1293272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":43,"alternative-id":["10.3389\/fphar.2024.1293272"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1293272","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"article-number":"1293272"}}